Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: An ex vivo study

American Journal of Obstetrics and Gynecology

Volumn 209, Issue 6, 2013, Pages 573.e1-573.e15

  Feinshtein, Valeria ^a   Erez, Offer ^a   Ben Zvi, Zvi ^a   Eshkoli, Tamar ^a   Sheizaf, Boaz ^a   Sheiner, Eyal ^a   Holcberg, Gershon ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

BeWo; breast cancer resistance protein (BCRP); cannabidiol; human placental perfusion; Jar cells; marijuana

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CANNABIDIOL; GLIBENCLAMIDE; MITOXANTRONE; NICARDIPINE; PHENAZONE; XENOBIOTIC AGENT;

ADULT; ARTICLE; BEWO CELL; BLOOD PLACENTA BARRIER; CELL LINE; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; COTYLEDON; DRUG EXPOSURE; DRUG PENETRATION; DRUG TRANSPORT; FEMALE; FETUS CIRCULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; JAR CELL; LONG TERM EXPOSURE; MATERNAL BLOOD; MATERNAL CIRCULATION; PLACENTA; PLACENTAL TRANSFER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84888641390     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.08.005     Document Type: Article

References (85)

1. Y.L. Hurd, X. Wang, V. Anderson, O. Beck, H. Minkoff, and D. Dow-Edwards Marijuana impairs growth in mid-gestation fetuses Neurotoxicol Teratol 27 2005 221 229
2. B. Park, J.M. McPartland, and M. Glass Cannabis, cannabinoids and reproduction Prostaglandins Leukot Essent Fatty Acids 70 2004 189 197
3. G.A. Dekker, S.Y. Lee, R.A. North, L.M. McCowan, N.A. Simpson, and C.T. Roberts Risk factors for preterm birth in an international prospective cohort of nulliparous women PLoS One 7 2012 e39154
4. M.R. Hayatbakhsh, V.J. Flenady, and K.S. Gibbons Birth outcomes associated with cannabis use before and during pregnancy Pediatr Res 71 2012 215 219
5. E. Kozer, and G. Koren Effects of prenatal exposure to marijuana Can Fam Physician 47 2001 263 264
6. A.R. Schier, N.P. Ribeiro, and A.C. Silva Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug Rev Bras Psiquiatr 34 Suppl 1 2012 104 110
7. A.W. Zuardi, J.A. Crippa, J.E. Hallak, F.A. Moreira, and F.S. Guimaraes Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug Braz J Med Biol Res 39 2006 421 429
8. A.W. Zuardi Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action Rev Bras Psiquiatr 30 2008 271 280
9. S. Deiana Medical use of cannabis. Cannabidiol: a new light for schizophrenia? Drug Test Anal 5 2013 46 51
10. C. Scuderi, D.D. Filippis, T. Iuvone, A. Blasio, A. Steardo, and G. Esposito Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders Phytother Res 23 2009 597 602
11. United Nations, United Nations Office on Drugs and Crime. Recommended methods for the identification and analysis of Cannabis and Cannabis products: United Nations Publications, 2009.
12. T. Iuvone, G. Esposito, D. De Filippis, C. Scuderi, and L. Steardo Cannabidiol: a promising drug for neurodegenerative disorders? CNS Neurosci Ther 15 2009 65 75
13. A. Ohlsson, J.E. Lindgren, S. Andersson, S. Agurell, H. Gillespie, and L.E. Hollister Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration Biomed Environ Mass Spectrom 13 1986 77 83
14. R. Mechoulam, and L. Hanus Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects Chem Phys Lipids 121 2002 35 43
15. M.L. Holland, D.T. Lau, J.D. Allen, and J.C. Arnold The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids Br J Pharmacol 152 2007 815 824
16. M.L. Holland, J.A. Panetta, and J.M. Hoskins The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells Biochem Pharmacol 71 2006 1146 1154
17. M.L. Holland, J.D. Allen, and J.C. Arnold Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1) Eur J Pharmacol 591 2008 128 131
18. N. Tournier, L. Chevillard, B. Megarbane, S. Pirnay, J.M. Scherrmann, and X. Decleves Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) Int J Neuropsychopharmacol 13 2009 905 915
19. R. Allikmets, L.M. Schriml, A. Hutchinson, V. Romano-Spica, and M. Dean A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance Cancer Res 58 1998 5337 5339
20. M. Ceckova-Novotna, P. Pavek, and F. Staud P-glycoprotein in the placenta: expression, localization, regulation and function Reprod Toxicol 22 2006 400 410
21. P. Krishnamurthy, and J.D. Schuetz Role of ABCG2/BCRP in biology and medicine Annu Rev Pharmacol Toxicol 46 2006 381 410
22. Q. Mao BCRP/ABCG2 in the placenta: expression, function and regulation Pharm Res 25 2008 1244 1255
23. P. Myllynen, M. Kummu, and E. Sieppi ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison Expert Opin Drug Metab Toxicol 6 2010 1385 1398
24. Z. Ni, and Q. Mao ATP-binding cassette efflux transporters in human placenta Curr Pharm Biotechnol 12 2011 674 685
25. R.W. Robey, K.K. To, and O. Polgar ABCG2: a perspective Adv Drug Deliv Rev 61 2009 3 13
26. K. Vahakangas, and P. Myllynen Drug transporters in the human blood-placental barrier Br J Pharmacol 158 2009 665 678
27. S.F. Zhou Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition Xenobiotica 38 2008 802 832
28. D.A. Evseenko, P. Murthi, and J.W. Paxton The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction Faseb J 21 2007 3592 3605
29. D.A. Evseenko, J.W. Paxton, and J.A. Keelan The xenobiotic transporter ABCG2 plays a novel role in differentiation of trophoblast-like BeWo cells Placenta 28 Suppl A 2007 S116 S120
30. P. Krishnamurthy, and J.D. Schuetz The ABC transporter Abcg2/Bcrp: role in hypoxia mediated survival Biometals 18 2005 349 358
31. C. Giaginis, A. Tsantili-Kakoulidou, and S. Theocharis Assessing drug transport across the human placental barrier: from in vivo and in vitro measurements to the ex vivo perfusion method and in silico techniques Curr Pharm Biotechnol 12 2011 804 813
32. M. Myren, T. Mose, L. Mathiesen, and L.E. Knudsen The human placenta - an alternative for studying foetal exposure Toxicol In Vitro 21 2007 1332 1340
33. G. Repetto, A. del Peso, and J.L. Zurita Neutral red uptake assay for the estimation of cell viability/cytotoxicity Nat Protoc 3 2008 1125 1131
34. F. Dumont, P.A. Marechal, and P. Gervais Cell size and water permeability as determining factors for cell viability after freezing at different cooling rates Appl Environ Microbiol 70 2004 268 272
35. A. Mittal, M.S. Pate, R.C. Wylie, T.O. Tollefsbol, and S.K. Katiyar EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis Int J Oncol 24 2004 703 710
36. V. Feinshtein, G. Holcberg, and A. Amash Nitrofurantoin transport by placental choriocarcinoma JAr cells: involvement of BCRP, OATP2B1 and other MDR transporters Arch Gynecol Obstet 281 2010 1037 1044
37. M. Golan, G. Schreiber, and S. Avissar Antidepressants increase beta-arrestin2 ubiquitinylation and degradation by the proteasomal pathway in C6 rat glioma cells J Pharmacol Exp Ther 332 2009 970 976
38. J.C. Arnold, P. Hone, M.L. Holland, and J.D. Allen CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells Pharmacol Rep 64 2012 751 757
39. A. Dudasova, S.D. Keir, M.E. Parsons, A. Molleman, and C.P. Page The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig Pulm Pharmacol Ther 26 2013 373 379
40. B.S. Harvey, K.S. Ohlsson, J.L. Maag, I.F. Musgrave, and S.D. Smid Contrasting protective effects of cannabinoids against oxidative stress and amyloid-beta evoked neurotoxicity in vitro Neurotoxicology 33 2012 138 146
41. A.J. Hill, C.M. Williams, B.J. Whalley, and G.J. Stephens Phytocannabinoids as novel therapeutic agents in CNS disorders Pharmacol Ther 133 2012 79 97
42. A. Juknat, M. Pietr, and E. Kozela Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells PLoS One 8 2013 e61462
43. A. Ligresti, A.S. Moriello, and K. Starowicz Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma J Pharmacol Exp Ther 318 2006 1375 1387
44. Y. Maor, J. Yu, P.M. Kuzontkoski, B.J. Dezube, X. Zhang, and J.E. Groopman Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium Genes Cancer 3 2012 512 520
45. M. Nabissi, M.B. Morelli, M. Santoni, and G. Santoni Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents Carcinogenesis 34 2013 48 57
46. H.J. Zhu, J.S. Wang, and J.S. Markowitz Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana J Pharmacol Exp Ther 317 2006 850 857
47. D. De Filippis, G. Esposito, and C. Cirillo Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis PLoS One 6 2011 e28159
48. M. Solinas, P. Massi, and A.R. Cantelmo Cannabidiol inhibits angiogenesis by multiple mechanisms Br J Pharmacol 167 2012 1218 1231
49. M. Kummu, E. Sieppi, K. Wallin, A. Rautio, K. Vahakangas, and P. Myllynen Cadmium inhibits ABCG2 transporter function in BeWo choriocarcinoma cells and MCF-7 cells overexpressing ABCG2 Placenta 33 2012 859 865
50. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
51. A. Amash, G. Holcberg, O. Sapir, and M. Huleihel Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: effect of magnesium sulfate J Interferon Cytokine Res 32 2012 432 441
52. E. Pollex, A. Lubetsky, and G. Koren The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta Placenta 29 2008 743 747
53. J. Khatri, S. Qassim, O. Abed, B. Abraham, A. Al-Lami, and S. Masood A novel extractionless hplc fluorescence method for the determination of glyburide in the human plasma: application to a bioequivalence study J Pharm Pharm Sci 4 2001 201 206
54. D.G. Moore, J.D. Turner, and A.C. Parrott During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study J Psychopharmacol 2009 [Epub ahead of print]
55. M.M. van Gelder, J. Reefhuis, A.R. Caton, M.M. Werler, C.M. Druschel, and N. Roeleveld Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study Drug Alcohol Depend 109 2010 243 247
56. H.L. Brown, and C.R. Graves Smoking and marijuana use in pregnancy Clin Obstet Gynecol 56 2013 107 113
57. D.M. Fergusson, L.J. Horwood, and K. Northstone Maternal use of cannabis and pregnancy outcome BJOG 109 2002 21 27
58. P.A. Fried, B. Watkinson, and A. Willan Marijuana use during pregnancy and decreased length of gestation Am J Obstet Gynecol 150 1984 23 27
59. S. Minnes, A. Lang, and L. Singer Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications Addict Sci Clin Pract 6 2011 57 70
60. J.R. Araujo, P. Goncalves, and F. Martel Modulation of glucose uptake in a human choriocarcinoma cell line (BeWo) by dietary bioactive compounds and drugs of abuse J Biochem 144 2008 177 186
61. J.R. Araujo, P. Goncalves, and F. Martel Effect of cannabinoids upon the uptake of folic acid by BeWo cells Pharmacology 83 2009 170 176
62. O.M. Habayeb, A.H. Taylor, S.C. Bell, D.J. Taylor, and J.C. Konje Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation Endocrinology 149 2008 5052 5060
63. O.M. Habayeb, A.H. Taylor, M. Finney, M.D. Evans, and J.C. Konje Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage JAMA 299 2008 1135 1136
64. S.P. Kenney, R. Kekuda, P.D. Prasad, F.H. Leibach, L.D. Devoe, and V. Ganapathy Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta Am J Obstet Gynecol 181 1999 491 497
65. M. Khare, A.H. Taylor, J.C. Konje, and S.C. Bell Delta9- tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription Mol Hum Reprod 12 2006 321 333
66. S. Ortigosa, B. Friguls, and X. Joya Feto-placental morphological effects of prenatal exposure to drugs of abuse Reprod Toxicol 34 2012 73 79
67. L. De Petrocellis, D. Melck, and A. Palmisano The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation Proc Natl Acad Sci U S A 95 1998 8375 8380
68. B. Park, H.M. Gibbons, M.D. Mitchell, and M. Glass Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta Placenta 24 2003 990 995
69. V. Feinshtein, G. Holcberg, and A. Amash Nitrofurantoin transport by placental choriocarcinoma JAr cells: involvement of BCRP, OATP2B1 and other MDR transporters Arch Gynecol Obstet 281 2010 1037 1044
70. I. Matok, R. Gorodischer, and G. Koren The safety of H(2)-blockers use during pregnancy J Clin Pharmacol 50 2010 81 87
71. H. Nordeng, A. Lupattelli, M. Romoren, and G. Koren Neonatal outcomes after gestational exposure to nitrofurantoin Obstet Gynecol 121 2013 306 313
72. M. Ostensen, and F. Forger How safe are anti-rheumatic drugs during pregnancy? Curr Opin Pharmacol 13 2013 470 475
73. P. Pavek, G. Merino, and E. Wagenaar Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b) pyridine, and transport of cimetidine J Pharmacol Exp Ther 312 2005 144 152
74. A. Tomaru, N. Morimoto, and M. Morishita Studies on the intestinal absorption characteristics of sulfasalazine, a breast cancer resistance protein (BCRP) substrate Drug Metab Pharmacokinet 28 2013 71 74
75. F.M. Wagenlehner, U. Hoyme, M. Kaase, R. Funfstuck, K.G. Naber, and G. Schmiemann Uncomplicated urinary tract infections Dtsch Arztebl Int 108 2011 415 423
76. Y. Zhang, H. Wang, J.D. Unadkat, and Q. Mao Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse Drug Metab Dispos 35 2007 2154 2158
77. G.G. Nahas The pharmacokinetics of THC in fat and brain: resulting functional responses to marihuana smoking Hum Psychopharmacol 16 2001 247 255
78. C.H. Ashton Pharmacology and effects of cannabis: a brief review Br J Psychiatry 178 2001 101 106
79. T. Nadulski, F. Pragst, and G. Weinberg Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract Ther Drug Monit 27 2005 799 810
80. D.J. Potter, P. Clark, and M.B. Brown Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology J. Forensic Sci 53 2008 90 94
81. A.J. O'Sullivan Does oestrogen allow women to store fat more efficiently? A biological advantage for fertility and gestation Obes Rev 10 2009 168 177
82. E.L. Karschner, E.W. Schwilke, and R.H. Lowe Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers J Anal Toxicol 33 2009 469 477
83. P. Myllynen, M. Kummu, and T. Kangas ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) in perfused term human placenta Toxicol Appl Pharmacol 232 2008 210 217
84. G. Holcberg, O. Sapir, and M. Tsadkin Lack of interaction of digoxin and P-glycoprotein inhibitors, quinidine and verapamil in human placenta in vitro Eur J Obstet Gynecol Reprod Biol 109 2003 133 137
85. H. Schneider, and A. Huch Dual in vitro perfusion of an isolated lobe of human placenta:method and instrumentation Contrib Gynecol Obstet 13 1985 40 47